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Background: There are a number of commercially available tissue-based surgical implants for use in
repairing abdominal wall defects. The role and effect of supplemental cross-linking present in some of
these implants has been questioned and evaluated in a number of recent experiments. In this review we
summarize results of preclinical animal studies evaluating tissue-based surgical implants used for
abdominal wall repair with a focus on currently available products and the inﬂuence of supplemental
cross-linking.
Methods: A search of PubMed, MEDLINE and article reference lists was undertaken. Inclusion criteria
were animal studies, abdominal wall hernias, and studies reporting on the main outcomes of tensile
strength, susceptibility to enzymatic degradation, antigenicity and immunogenicity, foreign body reac-
tion, tissue ingrowth, and complications. Exclusion criteria included those studies that only reported on
methods of ﬁxation, implantation or fenestration of mesh.
Results: A total of 21 articles that speciﬁcally compared non-cross-linked and supplemental cross-linked
tissue-based implants were reviewed. In addition, other studies that compared tissue-based implants,
which are not commercially available, were included where appropriate.
Conclusion: Supplemental cross-linking of collagen found in tissue-based surgical implants has not been
shown to adversely affect the strength of the implant or its ability to support long-term ingrowth of
tissue. Further studies need to be performed to determine if the differences in cross-linked and non-
cross-linked implants observed in animal models translate to differences in clinical performance.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
A growing number of tissue-based surgical implants have been
commercialized for hernia repair. Current tissue-based surgical
implants vary in terms of the source and processing of the tissue.
Collagen meshes can be obtained from either human (allogeneic) or
non-human (xenogeneic) sources. The tissue is processed by decel-
lularization, using both mechanical and chemical methods, leaving
only the extracellular matrix that functions as a scaffold following
implantation. The various processing methodologies employed have
the potential to alter the underlying physical and chemical structure
of the tissue scaffold, providing unique characteristics for each
implant, which may inﬂuence their performance in a clinical setting.
Table 1 provides an overview of the most commonly used tissue-
based surgical implants for abdominal wall repair.art).
ciates Ltd. Published by Elsevier LtOf the various processing methodologies, supplemental cross-
linking has been the most controversial.1 Native collagen contains
naturally occurring covalent cross-links that function to stabilize
the structure of the collagen protein providing mechanical strength
and protection from collagenase.2,3 In this respect all collagen-
based grafts are naturally cross-linked. Supplemental cross-
linking of collagen based surgical implants may occur by treat-
ment with chemical agents or via sterilization processes such as
gamma and electron beam irradiation.4 Therefore, some of the
Ïnon-cross-linkedÓ products may have some degree of supple-
mental cross-linking that occurs during sterilization. Although each
of these agents forms covalent bonds between molecules, they
differ in terms of which molecules the bonds link. As a result of the
variation in cross-linking structure, the use of different cross-
linking agents may result in differences in the mechanical
strength and biological functioning of the collagen matrix.5,6 Of the
commonly used biologic meshes, only Permacol, Collamend and
Peri-Guard are cross-linked.d. All rights reserved.
Table 1
Characteristics of commercially available tissue-based surgical implants for use in abdominal wall repairs included in this Review. (49e52).
Product name Manufacturer Tissue source Cross-linking
agent
Date of FDA
Approval
Method of decellularization Terminal
sterilization
Freeze-dried Refrigeration
required
CollaMend Davol, Inc. Warwick, RI Porcine dermis Carbodiimide 2006 Sodium sulﬁde, sodium
hypochlorite, HCl, H2O2
EO Yes No
Permacol Covidien Norwalk, CT Porcine dermis HMDI 2000 Acetone, enzymatic digestion Gamma
irradiation
No No
Peri-Guard Synovis Surgical
Innovations St. Paul, MN
Bovine pericardium Glutaraldehyde 1982a NaOH, propylene
oxide, ethanol
Liquid alcohol No No
AlloDerm LifeCell Corporation
Branchburg, NJ
Human dermis,
cadaveric
None Not required Ionic (sodium deoxycholate) None Yes Yes
Strattice LifeCell Corporation
Branchburg, NJ
Porcine dermal 2007 Proprietary E-beam
radiation
Yes No
XenMatrix Brennen Medical
St. Paul, MN
Porcine dermal 2003 N/A E-beam
radiation
No No
Surgisis Cook Biomedical
Bloomington, IN
Porcine small
intestinal mucosa
1999 Paracetic acid EO No No
Veritas Synovis Surgical
Innovations St. Paul, MN
Bovine pericardium 2003 NaOH, propylene oxide,
ethanol
Yes No No
EO ¼ ethylene oxide; H2O2 ¼ hydrogen peroxide; HCl ¼ hydrochloric acid; HMDI ¼ hexamethylene diisocyanate; N/A ¼ not available.
a Date for FDA clearance.
N.J. Smart et al. / International Journal of Surgery 10 (2012) 436e442 437
REVIEWTo be effective in promoting wound healing during abdominal
wall hernia repairs, the ideal implant would need to be biocom-
patible, durable enough to withstand physical and physiological
stresses, promote ingrowth of the host tissue, and resist adherence
to viscera.1,7 It is, however, difﬁcult to assess these characteristics in
a clinical setting. Therefore to evaluate effectively the different
implants in terms of these parameters we need to rely on preclin-
ical studies, especially those performed in vivo in animal models. To
date, no review has addressed the role of cross-linking in depth. In
this paper we review the literature reporting results from animal
studies comparing cross-linked and non-cross-linked tissue-based
surgical implants used in repairing abdominal wall hernias.
2. Methods
A literature search was undertaken to extract relevant articles from the
following databases: PubMed, MEDLINE and articles which came from the reference
lists of other articles. Search terms were: biologic mesh, AlloDermD, AllomaxÙ,
CollamendÙ, Flex HDD, FortaGenD, Peri-GuardD, PermacolÙ, StratticeD, SurgisisÙ
TutopatchD, VeritasD, XenmatrixÙ, porcine dermal collagen, bovine pericardium,
small intestine submucosa, human acelluar dermal matrix and hernia. Studies were
eligible for inclusion provided that they used animal models of either abdominal
wall hernia or subcutaneous implants, compared cross-linked and non-cross-linked
biologic meshes and reported clinically relevant main outcomes (tensile strength,
susceptibility to enzymatic degradation, antigenicity and immunogenicity, foreign
body reaction, tissue ingrowth, and complications). Studies comparing commer-
cially available with experimental biologic meshes were included as were studies
from the same research group using the same technique, but where the results for
the cross-linked and non-cross-linked meshes were presented in separate papers.
Studies were excluded if they were clinical studies in human subjects, only reported
on methods of ﬁxation, implantation or fenestration of mesh or were reviews, case
reports or conference abstracts. Searches were limited to English language articles.
All articles published until the end of May 2012 were reviewed for relevance and
appraisal. An initial screening consisted of the review of titles, abstracts and full
articles; a second screening determined the relevance of full article. Data was
extracted and reviewed by all three authors. The search strategy is summarized in
Fig. 1.
3. Results
The search terms yielded 323 records. A total of 310 records
were excluded on the grounds of not being in English, not being
animal studies, not comparing cross-linked with non-cross-linked
meshes or being review articles. A further 8 studies were identi-
ﬁed from the reference list of included studies. A total of 21
publications were included for review and are summarized in
Table 2. The quality of data, variety of animal species used,
heterogeneity of abdominal wall hernia model and number ofdifferent surgical techniques used for hernia repair precluded
a meta-analysis of the studies. The studies relating to each of the
clinically relevant outcomes are described below.4. Tensile strength
4.1. Rat studies
Of the 7 studies using rat models, one reported superior tensile
strength for non-cross-linked implant while 5 report superior
tensile strength for cross-linked implants. In a rat model of hernia
repair, the tensile strength of both Surgisis and Permacol three days
after implantationwas the same.8 However, at 28 days, Surgisis had
a signiﬁcantly greater tensile strength than Permacol; this differ-
ence was sustained through to 60 days. Conversely, another similar
study performed in rats indicated that at 3- or 6-months post-
implantation a cross-linked implant (either Peri-Guard or Perma-
col) had greater tensile strength than non-cross-linked implants
(Alloderm or Veritas).9 In this study, at 6 months, the tensile
strength of the non-cross-linked implants was weaker than the
native abdominal wall muscle. These results are supported by
a more recent study comparing 4 tissue-based surgical implants
implanted to repair full thickness abdominal wall defects in rats.
After 90 days, the strength of non-cross-linked implants (Surgisis
and InteXen LP) was lower than cross-linked implants (Pelvicol and
Pelvisoft).10 Comparing Gynemesh, Pelvicol, Pelvisoft, or Surgisis in
a rat ventral hernia model also detected no difference in tensile
strength after 3 months.11 Another study compared the use of
Permacol with Strattice for the repair of abdominal wall defects in
rats.12 In this study, the tensile strength of Permacol was signiﬁ-
cantly greater than Strattice at 3-, 6-, and 12-months post-
implantation. De Castro Bras et al reported that the maximum
load sustained by the implantetissue interface before mechanical
failure was signiﬁcantly higher for Permacol compared to Colla-
mend, Alloderm or Surgisis at 3 months.13 A similar study by Bro-
derick et al comparing Alloderm, Collamend and Permacol was
limited by technical problems during tensile testing and statistical
comparisons were not possible due to limited sample size.144.2. Large animal studies
Results from 4 studies in larger animals consistently indicate
that cross-linking does not have a major impact on the strength of
Potentially relevant studies identified 
and screened for retrieval
n = 323
Studies retrieved for more detailed 
evaluation 
n = 111
Studies excluded by filters “other 
animal” or “English” n =212
Studies to be included in the review
n = 13
Total number of studies included in 
the review
n = 21
Studies excluded due to:
Non-comparative study n = 62
Did not use animal model n = 1
Review article n = 35
Studies identified from the reference lists 
of included studies n = 8
Fig. 1. Article selection for biologic mesh review.
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linked implants (Peri-Guard and Permacol) and non-cross-linked
implants (Alloderm and Veritas) consistently had similar tensile
strength (measured 1- to 12-months post-implantation).15 These
results are consistent with a study in which DermaMatrix, Allo-
derm, and Permacol were implanted into swine to repair a full
thickness ventral fascial defect.16 At 15 weeks, the tensile strengths
of all three implants were comparable. Although some studies have
demonstrated differences in the tensile strength of tissueeimplant
interface between cross-linked and non-cross-linked implants up
to 1 month after implantation, these have not been maintained at 6
months in both rabbit17 and primate models.18
4.2.1. Susceptibility to enzymatic degradation
In terms of tissue-based surgical implants used for abdominal
wall repair, Surgisis demonstrated a rapid and progressive degra-
dation compared with Permacol (cross-linked), which had no
evidence of scaffold degradation at 112 days. AlloDerm was
partially degraded at 112 days.19 Xu et al examined the suscepti-
bility to enzymatic degradation of 3 experimental non-cross-linked
porcine dermal implants in vitro prior to in vivo studies.20 All three
implants had a degradation proﬁle indistinguishable from native
dermal tissue.
4.2.2. Antigenicity and immunogenicity of chemically cross-linked
collagen
Antigenicity of commercially available biologic meshes has been
investigated in a primate model by only a single group ofresearchers. Overall humoral responses did not differ signiﬁcantly
between cross-linked and non-cross-linked porcine derived
meshes (Surgisis, Collamend and Permacol), but there was a quali-
tative difference in anti-a-galactose antibodies between Surgisis
and the cross-linked porcine dermal implants.18 Using the same
primate model, experimental non-cross-linked porcine meshes
from wild type pigs elicited a signiﬁcant increase in anti-a-galac-
tose antibodies that was minimized if the implants were treated
with galactosidase.20 The anti-a-galactose antibody titre elicited by
the galactosidase treated non-cross-linked porcine dermal collagen
implant Strattice was minimal and similar to that seen with cross-
linked porcine dermal collagen.21
4.2.3. Foreign body reaction
The foreign body reaction of several implants was studied in
a rat ventral hernia model.19 Two distinct patterns of inﬂammatory
reaction were elicited by tissue-based surgical implants: i) low
grade chronic inﬂammation showing mononuclear cell inﬁltratese
cellular response consistent with slow degrading or permanent
implants e observed with the cross-linked implants, Permacol,
TissueMend and CuffPatch, the latter eliciting the highest inﬂam-
mation reaction, ii) an acute inﬂammatory reactionwith temporary
dense accumulation of mononuclear cells whose duration appears
to be strongly correlated with the degradation and remodeling
rates of the non-cross-linked implants, AlloDerm and Surgisis. For
the latter implant, the mononuclear cells were more evenly spread
throughout the implant. Multinucleated giant cells, typically asso-
ciated with a foreign body reaction, have been marginally observed
Table 2
Overview of articles reviewed.
Year Lead author Species N Product(s) Wound Follow-up
Durationa
Rats
2006 Petter-Puchner SpragueeDawley rats 10 Surgisis Full-thickness defect in
abdominal rectus muscles
(chronic wound)
17 days
2006 Valentin SpragueeDawley rats 126 GraftJacket, Restore, CuffPatch,
TissueMend,
Permacol
Defect of the musculotendinous
portion of the ventral lateral
abdominal wall
112 days
2007 Gaertner SpragueeDawley rats 26 Peri-Guard, Veritas, Alloderm,
Permacol
Full-thickness abdominal wall
(midline or lateral; chronic vs
acute)
6 months
2007 Richter SpragueeDawley rats 24 AlloDerm, ENDURAGen Subcutaneous implantation 8 weeks
2007 Trabuco Wistar rats 63 Gynemesh, Pelvicol, Pelvisoft,
Surgisis
Midline abdominal wall defects 3 months
2008 Ayubi SpragueeDawley rats 48 Permacol, Surgisis Full-thickness fascial defect of
rectus abdominis muscle
60 days
2008 Petter-Puchner SpragueeDawley rats 10 Permacol Full-thickness defect in
abdominal rectus muscles
(chronic wound)
2 weeks
2010 de Castro Bras Wistar-Han rats 24 Permacol, experimental
non-cross-linked
porcine dermal collagen
Ventral midline defect 12 months
2010 Konstantinovic Wistar rats 186 Surgisis, Pelvicol, Pelvisoft,
InteXen LP
Full-thickness abdominal wall
defects
90 days
2011 Mulier SpragueeDawley rats 89 Permacol, Strattice Full-thickness midline defect 12 months
2011 Petter-Puchner SpragueeDawley rats 48 CollaMend, Peripatch, Surgisis,
Tutomesh
IPOM rat model 60 days
2012 de Castro Bras SpragueeDawley rats 81 AlloDerm, CollaMend,
Permacol, Surgisis
Ventral midline defect 6 months
2012 Broderick SpragueeDawley rats 108 AlloDerm, Permacol, CollaMend ventral abdominal wall defects 180 days
Mammals
2010 Butler Hartley guinea pigs 58 CollaMend, Strattice Full-thickness abdominal wall 4 weeks
2010 Stanwix Gottingen miniature swine 15 DermaMatrix, AlloDerm,
Permacol
Full-thickness ventral fascial
defect
15 weeks
2011 Deeken Yucatan minipigs 48 PeriGuard, Permacol, AlloDerm,
Veritas
Full-thickness bilateral
abdominal wall defects
12 months
2011 Melman Yucatan minipigs 20 Alloerm, PeriGuard, Permacol,
Strattice,
Veritas
Full-thickness fascial defects 1 month
2012 Pascual Rabbits 40 CollaMend, Permacol, SurgiSIS,
ePTFE
Partial thickness abdominal
wall defects
180 days
Non-human primates
2008 Sandor Caribbean vervet monkeys 33 SurgiSIS, Permacol, CollaMend Full-thickness abdominal wall
defects
6 months
2009 Connor Caribbean vervet monkeys 24 Strattice Full-thickness abdominal wall
defects
6 months
2009 Xu Caribbean vervet monkeys 12 þ 36 3 types of experimental non-
cross-linked
porcine dermal collagen
Subcutaneous implant &full-
thickness abdominal wall
defects
60 days & 6 months
a Maximal length of follow-up for any 1 group.
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Puchner et al noted pronounced foreign body reaction to both
Surgisis and Collamend in a rat model of intraperitioneal onlay
mesh (IPOM) repair at 60 days.22 In a swine ventral herniamodel, at
15weeks, Permacol had a lower level of inﬁltration of inﬂammatory
cells compared with either DermaMatrix or Alloderm.16
4.2.4. Tissue ingrowth
Histological analysis after implantation for only a short duration
has shown some differences between cross-linked and non-cross-
linked implants. Permacol was compared with Surgisis (non-
cross-linked) in a rat ventral hernia model.8 At 60 days, collagen
deposition was mostly restricted to the periphery of Permacol.
Surgisis exhibited a higher strength of incorporation at the expense
of its degradation. At 60 days Surgisis was almost completely
degraded and was replaced by scar tissue, characterized by larger
collagen deposition and neo-vascularization. In addition, when
AlloDerm and Permacol were subcutaneously implanted in rats,AlloDerm had signiﬁcantly greater soft tissue ingrowth and
microvascular density at both four and eight weeks.23
Rat studies with longer durations of implantation before histo-
logical analysis have demonstrated different ﬁndings to the short-
term studies. One of the ﬁrst studies compared cross-linked
implants (Permacol and Peri-Guard) with two non-cross-linked
meshes (Veritas and AlloDerm) used to repair ventral hernias in
rats.9 After 3 months, the level of cellular ingrowth and neo-
vascularization was similar in the 4 implants. However, the cross-
linked implants demonstrated much higher mechanical support
of the defective abdominal wall for up to 6 months. In another
study, Permacol was compared with non-cross-linked collagen
matrix subcutaneously implanted in rats and followed for 12
months.24 At shorter time points (3 and 6 months), the non-cross-
linked implant had more evidence of cellular inﬁltration than
implant that was cross-linked. At 12 months, there was no differ-
ence in tissue ingrowth between the two implant types. The same
research group recently published a comparison of AlloDerm,
N.J. Smart et al. / International Journal of Surgery 10 (2012) 436e442440
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cross-linked implants demonstrated rapid tissue ingrowth, but
were remodeled and resorbed very quickly. Permacol showed
increasing tissue integration up to 6 months, whereas Collamend
demonstrated poor tissue integration, particularly on the surface
adjacent to the peritoneum.13 Broderick et al also compared Per-
macol with Collamend and Alloderm and replicated the ﬁndings of
rapid inﬁltration for Alloderm associated with early remodeling
and low tensile strength, progressive cellular penetration over the
study period for Permacol and minimal cellular inﬁltration and
encapsulation for Collamend.14 Finally, there were no signiﬁcant
differences in collagen inﬁltration or endovascular ingrowth in
Permacol (cross-linked) or Strattice (non-cross-linked) at 3 or 6
months after being implanted for the repair of abdominal wall
defects in rats.12 During the ﬁrst month, most of the vascular
ingrowth occurred at or via the hair follicles. Comparisons between
the implants were not made at 12 months given the signiﬁcant
thinning and disorganization of Strattice at that time point.
4.3. Large animal studies
Similarly, studies with larger animals also indicate that inﬁl-
tration may preferentially favor non-cross-linked implants in the
short term but not in the long term. In a porcine model of ventral
hernia repair, non-cross-linked implants (Alloderm, Strattice, and
Veritas) were compared with cross-linked implants (Permacol and
Peri-Guard).25 At 1 month post-implantation, all 3 non-cross-
linked implants had greater tissue ingrowth (cell inﬁltration, ECM
deposition, and neovascularization) than the cross-linked implants.
In a similar porcine model, DermaMatrix, Alloderm, and Permacol
had similar degree of inﬁltration and vascularity at 15 weeks.16 In
yet another porcine model of ventral hernia repair, non-cross-
linked implants (Alloderm and Veritas) displayed more tissue
ingrowth (cell inﬁltration, ECM deposition, and neovascularization)
at one month than either cross-linked implant (Permacol and Peri-
Guard).15 However, at 12 months no signiﬁcant differences were
seen across the implants.
In a study comparing porcine acellular dermal matrices (native
and cross-linked) in a guinea pig ventral hernia model, the native
implant (Strattice) demonstrated greater cellular inﬁltration and
vascular density at 4 weeks than similar implants that had been
cross-linked (CollaMend).26 However, in a rabbit model comparing
cross-linked and non-cross-linked biologic prostheses, although
the non-cross-linked prosthesis showed better tissue ingrowth in
the early stages, they had more intense inﬂammatory reaction and
more rapid degradation than the cross-linked prostheses.17 At 14
days, cross-linked prostheses induced up-regulated collagen 1a1
and 3a1 gene expression, while non-cross-linked only showed
increased collagen III protein expression at 90 days. The cross-
linked collagen prostheses may have promoted less tissue
ingrowth than the non-cross-linked meshes, but they became
gradually replaced by good quality host tissue and were less rapidly
degraded, leading to improved stress resistance in the long term.
Primate models demonstrated variable responses to cross-linking,
with limited integration for Surgisis, Collamend and Permacol at
up to 6 months, but uniform remodeling of non-cross-linked
porcine dermal collagen (Strattice) at 3 months,18,20,21
4.3.1. Complications
Adhesions have been reported to be more frequent with cross-
linked implants in guinea pigs,26 but this ﬁnding was not repli-
cated in rats with several studies demonstrating no difference
between cross-linked and non-cross-linked implants.8,9,12,14
However, one study in swine indicated that Permacol was associ-
ated with fewer adhesions than DermaMatrix or Alloderm (non-cross-linked implants).16 Seroma formation rate was variable and
not related to cross-linking in one study.14
Three animal studies by Petter-Puchner and co-workers showed
adverse effects in experimental ventral hernia repair, with Colla-
mend, equine pericardium (Peripatch), bovine pericardium (Tuto-
mesh), Surgisis and Permacol. Abscedation, lack of tissue
incorporation and putrid seroma accompanied by bacterial colo-
nization were observed in all samples of the Surgisis study.27 The
implant was completely degraded after 17 days. In the Permacol
study, strong local inﬂammation reaction was observed with signs
of foreign body reaction with lack of tissue incorporation.28 Three
cases of transcutaneous migration of implants were also observed,
which have been not reported elsewhere with Permacol and other
tissue based surgical implants. In the third study, all meshes (Col-
lamend, Surgisis, Peripatch and Tutomesh) exhibited severe adhe-
sions, marked inﬂammation and lack of integration. Surgisis in
particular was noted to undergo delamination, shrinkage and
wrinkling of the mesh.225. Discussion
If biologic prostheses are to be used in abdominal wall hernia
repair, they need to remain structurally intact for a length of time
adequate enough for the host’s neo-collagen to be deposited onto
the scaffold and for the implant to undergo remodeling. Conse-
quently durability of the prostheses has been postulated as the key
to a successful repair.7
In this article we have reviewed 21 preclinical in vivo studies
that compared supplemental cross-linked and non-cross-linked
tissue-based surgical implants for repair of the abdominal wall.
Very few of the studies were of a highly controlled design in which
only one aspect of the implant, namely cross-linking, was altered.
Most studies compared different implants that are commercially
available. The implants vary not only in terms of the presence of
supplemental cross-links, but also in regards to the source of the
tissue (both the species and the anatomical location), age of the
animal, terminal sterilization, and other processing method
employed (e.g. freeze-drying). Therefore, in the studies where
a difference was observed across different implants, it is difﬁcult to
isolate which aspect of the implant had the greatest inﬂuence.
Despite numerous studies demonstrating biocompatibility and
tissue in-growth with cross-linked collagen implants it has been
suggested that supplemental cross-linking may limit host tissue in-
growth into the implant.1 A number of studies have demonstrated
that in the short term, non-cross-linked meshes may have a higher
degree of cellular inﬁltration, but this difference does not persist.
Tissue ingrowth in meshes that are cross-linked does not differ
from non-cross-linked meshes in the long-term quantitatively, but
may be qualitatively different in the expression of collagen genes.17
It is also important to note that a number of these studies simply
focused on the number of cells present within the mesh. However,
the number of cells inﬁltrating the mesh may not adequately
represent the level of penetration or ingrowth of the tissue. In one
rodent model, the level of cellular density was not consistent with
the degree of penetration (i.e. implants with a low density of
inﬁltrating cells actually found cells dispersed throughout the
entire implant).24 There needs to be a trade-off between short-term
and long-term results. For instance, non-cross-linked meshes may
have a higher degree of cellular inﬁltration over the short-term, but
they also degrade more quickly.29,30 If it is important to have
a durable product, then having quick inﬁltration may not be as
critical. This appears to be supported by the clinical data presented
in systematic reviews that shows a superior recurrence rate for
cross-linked compared to non-cross-linked biologic meshes used in
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be subjected to increased collagenase activity.31,32
Native collagen degrades quickly in the presence of collagenases
and other enzymes.30,33 The same is true for decellularized
collagen-based meshes. Numerous studies have demonstrated that
supplemental cross-linking diminishes the susceptibility of
collagen-based products to enzymatic degradation.29,34e40 In
laboratory studies, using standardized tests of tensile strength,
Deeken and co-workers demonstrated in a series of papers that
some cross-linked and non-cross-linked materials exhibited very
similar properties. The authors concluded that variables other than
cross-linking, such as decellularization/sterilization treatments or
species/tissue type also contribute to the properties of the pros-
theses,41 although crucially cross-linked prostheses were more
likely to retain tensile strength after repetitive loading42 and
especially after a period of enzymatic degradation.43
Collagen implants, whether cross-linked or not, have been used
for a sufﬁcient time in humans to indicate that adverse reactions
due to immune reactions are rare.44 It is difﬁcult to draw any
conclusions regarding complications that have arisen with the use
of tissue-based surgical implants for abdominal wall repair in
preclinical studies because of the limited and inconsistent reports.
As observed from the studies of Petter-Puchner et al, adverse events
can occur with tissue-based surgical implants regardless of
whether they have had supplemental cross-linking,22,27,28 although
it is worth noting that the research methods used by this group
have been criticized and their ﬁndings have not been
replicated.45,46
6. Conclusion
Supplemental cross-linking of collagen found in tissue-based
surgical implants has not been shown to adversely affect the
strength of the mesh or its ability to support long-term ingrowth of
tissue in animal models. Furthermore, supplemental cross-linking
of tissue-based surgical implants provides a biocompatible scaf-
fold that is less susceptible to enzymatic degradation, providing
a potentiallymore durable scaffold than non-cross-linked implants.
Further studies need to be performed to determine if the differ-
ences in cross-linked and non-cross-linked implants observed in
animal models translate into differences in clinical performance.
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